Verrill's patent attorneys specialize in assisting biotech and life science clients at every level from university research, to startups, to mid-market and large corporations. We understand the challenges of leveraging funding for product development from dynamic research programs in a competitive environment. We're experienced in US and foreign patent prosecution, patent litigation, post-grant proceedings, opinions related to non-infringement, invalidity, freedom to operate, inventorship disputes, licensing, portfolio analysis, and competitor analysis.

Our patent prosecutors have extensive experience dealing with patent eligibility matters and work with a wide array of technologies including the following:

  • Antibodies
  • Aptamers
  • Aquaculture
  • Biofuels
  • Cancer therapies and vaccines
  • CAR T-cells
  • Cell culture
  • Chromatography systems
  • CRISPR technology
  • Drug delivery vehicles
  • Drug formulation
  • ELISA
  • Fluorescence in situ hybridization
  • Food science and enzymes
  • Gene therapy
  • Genetic adjuvants
  • Genomics
  • Immunotherapeutics
  • Industrial chemical and biochemical processes
  • Medical diagnostics
  • Microscopy technology and image analysis
  • Modular agricultural systems
  • Nanoparticles
  • Nucleic acids
  • Nutritional biochemistry
  • Probes
  • Proteins
  • Sequencing technology
  • Small molecule pharmaceuticals
  • Spectrometry
  • Stem cells
  • Targeting of drugs and biologics
  • Test kits
  • Transgenic animals
  • Treatment of diabetes and metabolic diseases
  • Viral vectors

Examples of how our patent attorneys have helped their biotech clients include:

  • Quickly established a patent portfolio in the competitive CAR T-cell space to support funding efforts of a biotech startup.
  • Assisted an instrumentation company in an inventorship dispute with its research collaborator, resulting in the company establishing its own patent portfolio.
  • Obtained broad patent coverage for a biologics formulations company to support its partnering efforts.

Firm Highlights

Matter

Management Inefficiency

Verrill represented Emera in its 2017 distribution rate case before the Maine PUC, which included: defeating Staff's proposed reduction to allowed return on equity for "management inefficiency;" approval of new expenditures, such as an...

Blog

Financial Institutions . . . In the News

Hundreds of business owners filing federal aid applications with lenders. ( Portland Press Herald 4.6.2020) Maine Securities Administrator Judith Shaw cautions to be careful of scammers. ( Central Maine 4.6.2020) New Dimensions Federal Credit...

Matter

Management Audit

Verrill represented Emera in its 2016 distribution rate case before the Maine PUC. The case involved issues relating to significant new capital investments, including Emera's new customer information system and a controversial substation investment...

Blog

Commercial Co-Ventures: What You Need to Know During a Pandemic

News

Available Take-Home Methadone Doses for Patients

Attorney Jim Cohen was mentioned in a Portland Press Herald article, "Methadone restrictions relaxed during pandemic, but not for everyone." The article describes the recent relaxed federal restrictions for the drug, due to the...

Publication/Podcast

Should Health Care Employers Prepare for COVID-19 As A Work-Related Injury?

While we know that everyone is being bombarded with COVID-19 recommendations, advice, news, and data, another important issue to manage in the workplace is the possibility of COVID-19 infection, if acquired at work and...

Event

2020 OHRP Exploratory Workshop

Health care attorney Emily Fogler will be presenting at the 2020 OHRP Exploratory Workshop in the third session, discussing sharing responsibilities and protecting participants - redefining roles in the single IRB era. Stay tuned...

Event

Central Maine Human Resources Association Chapter Meeting: Flexible Work Options

Employment and labor attorney Tawny Alvarez will be presenting at the Central Maine Human Resources Association Chapter Meeting. This month's chapter meeting will focus on flexible work options. Tawny will discuss how policy impacts...

Publication/Podcast

Executive Order Temporarily Modifies Requirements for In-Person Notarization and Acknowledgement in Maine

On April 8, 2020, Maine Governor Janet Mills signed an Executive Order titled “An Order Temporarily Modifying Certain In-Person Notarization and Acknowledgement Requirements.” The purpose of this Order is to enable citizens to execute...

News

Maine's 'Thoughtful' and 'Aggressive' Response to COVID-19

On Wednesday, April 8, the Portland Regional Chamber of Commerce had its first ever virtual Eggs & Issues, moderated by Jim Cohen, volunteer board president of the Portland Community Chamber of Commerce and Verrill...